Semble Raises $15 Million in Series B
Semble, a London, UK-based healthcare software company, has raised $15 million in Series B funding, bringing its total raised to $27M.
The round was led by Mercia Ventures, with participation from Octopus Ventures, Smedvig Ventures, and Triple Point.
Mercia Ventures is a UK-based venture capital firm investing in high-growth startups and small businesses across sectors like Software, Healthcare, Consumer, and Deep Tech. Typically, Mercia invests up to £10 million per company. With 11 offices across the UK, Mercia is part of Mercia Asset Management, which also offers debt and private equity support to a diverse portfolio of businesses.
The company will use the new funding to consolidate its UK market presence and expand into France, where it recently launched operations.
Founded in 2018 by Christoph Lippuner and Mikael Landau, Semble provides an integrated clinical system designed to streamline and enhance administrative and operational workflows for healthcare businesses. The platform supports over 10,000 healthcare professionals across multiple specialties in the UK and France. It automates routine tasks, enables secure patient data exchange, and improves interoperability with third-party systems, including hospitals, labs, and pharmacies.
Funding Details
Company: Semble Technology Limited
Raised: $15M
Round: Series B
Funding Date: October 2024
Lead Investor: Mercia Ventures
Additional Investors: Octopus Ventures, Smedvig Ventures, Triple Point
Company Website: https://www.semble.io/
Software Category: Healthcare Practice Management